Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens

References

1. Deitz W H., Cook T M., Goss W A. Mechanism of action of nalidixic acid on Escherichia coli III. Conditions required for lethality. J Bacterial 1966; 91:768–773
   [Google Scholar]
2. Smith J T. Awakening the slumbering potential of the 4-quinolone antibiotics. Pharm J 1984; 233:299–305
   [Google Scholar]
3. Smith J T., Lewin C S. Chemistry and mechanisms of action of the quinolone antibacterials. In Andriole V. ed The quinolones. London: Academic Press; 198823–82
   [Google Scholar]
4. Lewin C S., Amyes S G B. The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. J Med Microbiol 1989; 30:227–231
   [Google Scholar]
5. Lewin C S., Amyes S G B., Smith J T. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16. EurJ Clin Microbiol Infect Dis 1989; 8:731–733
   [Google Scholar]
6. Lewin C S., Amyes S G B. Conditions required for the bactericidal activity of pefloxacin and fleroxacin against Escherichia coli KL16. J Med Microbiol 1990; 32:83–86
   [Google Scholar]
7. Zeiler H-J., Grohe K. The in-vitro and in-vivo activity of ciprofloxacin. Eur J Clin Microbiol 1984; 3:339–343
   [Google Scholar]
8. Ratcliffe N T., Smith J T. Norfloxacin has a novel bactericidal mechanism unrelated to that of other 4-quinolones. J Pharm Pharmacol 1985; 37:92
   [Google Scholar]
9. Smith J T. Frequency and expression of mutational resist ance to the 4-quinolone antibacterials. Scand J Infect Dis 1986; 49:suppl115–123
   [Google Scholar]
10. Lewin C S., Allen R A., Amyes S G B. Potential mechanisms of resistance to the modem fluorinated 4-quinolones. J Med Microbiol 1990; 31:153–161
    [Google Scholar]
11. Watanabe M., Inoue M., Mitsuhashi S. In vitro activity of amifloxacin against outer membrane mutants of the family enterobacteriaceae and frequency of sponta-neous resistance. Antimicrob Agents Chemother 1989; 33:1837–1840
    [Google Scholar]
12. Smith J T. In-vitro and in-vivo mutation frequencies to resistance. Do they correlate in the long term?. In Crumplin G C. ed 4-quinolone antibacterial agents in vitro . Heidelberg: Springer Verlag; In press
    [Google Scholar]
13. Schacht P., Hullman R. Changes of susceptibility of infecting organisms to ciprofloxacin during treatment. Abstracts of the Congress on Bacterial and Parasitic Drug Resistance, Bangkok; 1986109
    [Google Scholar]
14. Suzuki K., Nagata Y., Naide Y., Horiba M. Clinical study of strains of Pseudomonas aeruginosa and Serratia marces-cens resistant to new quinolones in complicated urinary tract infection. Rev Infect Dis 1989; 11:Suppl 5S969–S970
    [Google Scholar]
15. Lewin C S., Howard B M A., Ratcliffe N T., Smith J T. 4-quinolones and the SOS response. J Med Microbiol 1989; 29:139–144
    [Google Scholar]
16. Lewin C S., Smith J T. Bactericidal mechanisms of ofloxacin. J Antimicrob Chemother 1988; 22:Suppl. C1–8
    [Google Scholar]